To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus

NCT05926414 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

15000

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Enavogliflozin
DRUG: Enavogliflozin

Sponsor

Daewoong Pharmaceutical Co. LTD.